Growth Metrics

Fulgent Genetics (FLGT) Free Cash Flow (2016 - 2026)

Fulgent Genetics' Free Cash Flow history spans 12 years, with the latest figure at $1.9 million for Q1 2026.

  • On a quarterly basis, Free Cash Flow rose 120.71% to $1.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$113.2 million, a 257.97% decrease, with the full-year FY2025 number at -$124.2 million, down 545.09% from a year prior.
  • Free Cash Flow hit $1.9 million in Q1 2026 for Fulgent Genetics, up from -$98.6 million in the prior quarter.
  • Over the last five years, Free Cash Flow for FLGT hit a ceiling of $183.1 million in Q1 2022 and a floor of -$98.6 million in Q4 2025.
  • Historically, Free Cash Flow has averaged $5.8 million across 5 years, with a median of $3.2 million in 2024.
  • Biggest five-year swings in Free Cash Flow: surged 247.82% in 2024 and later tumbled 887.91% in 2025.
  • Tracing FLGT's Free Cash Flow over 5 years: stood at $28.5 million in 2022, then plummeted by 58.48% to $11.8 million in 2023, then plummeted by 208.3% to -$12.8 million in 2024, then crashed by 670.13% to -$98.6 million in 2025, then skyrocketed by 101.92% to $1.9 million in 2026.
  • Business Quant data shows Free Cash Flow for FLGT at $1.9 million in Q1 2026, -$98.6 million in Q4 2025, and $11.6 million in Q3 2025.